Why Hims & Hers Heath Shares Are Surging Today
Semis Have Opportunities Within Volatility and Attractive Valuations - BofA
Hims & Hers Appoints Former Novo Nordisk President to Board
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Teva's Migraine Treatment Found Effective For Children As Young As 6
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
$100 Invested In Nova 15 Years Ago Would Be Worth This Much Today
Nova Analyst Ratings
KLA Corp. in Spotlight as Citi Make Top Pick; Firm Also Moves Teradyne Higher
Netflix, Delta Air Lines And HubSpot Are Among Top 10 Large Stocks That Performed Worst This Week (July 7-July 13): Are The Others In Your Portfolio?
Piper Sandler Maintains Overweight on Monday.Com, Maintains $270 Price Target
Adobe, Snowflake, Others in Focus as Piper Sandler Weighs in on Enterprise Software
Argus Upgrades Teva to Buy, Cites Recent Drug Approvals
Wix.com Gains as Company Authorizes $200M Buyback
Teva Focus of FTC Investigation Over Inhaler Patents
Snowflake, Fox, Global-E Online Added to America's Conviction List: Goldman
Teva Pharmaceuticals Presents 4th Interim Analysis Of PEARL Migraine Prevention Study At EAN Congress; New Sub-Analysis Highlights Potential Negative Impact Of Treatment Pauses On Patient Outcomes
Teva Pharmaceutical Indus Analyst Ratings